In the last few days, WHO/International Agency for Research on Cancer (IARC) has classified radiofrequency electromagnetic fields as emitted by mobile phones as possibly carcinogenic to humans (Group 2B)...
Combination Therapy Shows Promise For Rare, Deadly Cancer Caused By Asbestos
6/02/2011
Pleural mesothelioma patients who undergo lung-sparing surgery in combination with photodynamic therapy (PDT) show superior overall survival than patient treated using the conventional therapy of extrapleural pneumonectomy (EPP) (or en bloc removal of the lung and surrounding tissue) with PDT, indicates new research from the Raymond and Ruth Perelman School of Medicine at the U...
In a multicenter clinical trial, UT Southwestern Medical Center researchers have found that higher doses of stereotactic radiation therapy requiring fewer treatments are safe and effective for patients with low-to-intermediate-risk prostate cancer...
Cause And Potential Treatment Found For Cancer Drug's Kidney Toxicity
6/02/2011
Scientists may have a way to make the powerful cancer drug cisplatin less toxic to the kidneys and more effective against some cancers. The chemotherapeutic agent used in combination with other drugs for a variety of cancers, results in kidney damage or failure in about 30 percent of users, although the mechanism has been unclear...
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced results from the Phase 1b portion of its Phase 1b/2 clinical study of ficlatuzumab in combination with gefitinib (Iressa(TM)) in Asian subjects with non-small cell lung cancer (NSCLC)...
Until a decade, it was believed that differences between people were due solely to the existence of genetic changes, which are alterations in the sequence of our genes. The discoveries made during these last ten years show that beings with the same genetics like the twins and cloned animals may have different characteristics and disease due to epigenetic changes...
New Grant To Study How Pediatric Brain Tumor, Ependymoma, Develops
6/02/2011
Armed with new grant support, investigators at Nationwide Children's Hospital plan to examine how a common gene of the nervous system leads to the development of a devastating brain tumor, ependymoma. Robert A...
Non-Small Cell Lung Cancer Patients Benefit From Less Toxic Combination Of Erlotinib And Bevacizumab
6/02/2011
The standard treatment for patients with advanced non-small cell lung cancer (NSCLC) is a combination of two old-fashioned cytotoxic chemotherapy drugs. The combination, however, comes with substantial toxicity. Now, Fox Chase Cancer Center researchers report that a combination of two molecularly-targeted agents may provide similar therapeutic benefit with less toxicity...
Nuvilex, Inc. Announces Favorable Phase II Clinical Trial Results For Pancreatic Cancer
6/02/2011
Nuvilex, Inc. (PINK SHEETS: NVLX) announces the favorable results of a completed Phase II clinical trial carried out in Europe against pancreatic cancer. The treatment technology used in this trial was recently acquired by Nuvilex. The trial demonstrated both efficacy and an improvement in quality of life, due in large part to the reduction in toxicity levels from lower dose chemotherapy...
ApoCell Launches Revolutionary Circulating Cancer Cell Detection System
6/02/2011
ApoCell, Inc. announced today that it has completed the first prototype to commercialize a revolutionary technology that improves the detection of more types of cancer cells circulating in the blood, including rare cell types that have previously gone undetected...